Cyclosporin A for IVIG Nonresponders
- 28 August 2016
- book chapter
- Published by Springer Nature
- p. 187-194
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Challenges of Frontier Science is a Role for Young Pediatric Cardiologists, and Standardization of Medical Treatment is a Role for Experienced PhysiciansPediatric Cardiology and Cardiac Surgery, 2012
- Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2009–2010 Nationwide SurveyJournal of Epidemiology, 2012
- Ulinastatin, a Urinary Trypsin Inhibitor, for the Initial Treatment of Patients With Kawasaki DiseaseCirculation, 2011
- ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki diseaseThe Pharmacogenomics Journal, 2011
- Common variants in CASP3 confer susceptibility to Kawasaki diseaseHuman Molecular Genetics, 2010
- Infliximab Treatment of Intravenous Immunoglobulin–Resistant Kawasaki DiseaseThe Journal of Pediatrics, 2008
- ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysmsNature Genetics, 2007
- Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulinModern Rheumatology, 2004
- Re‐treatment for immune globulin‐resistant Kawasaki disease: A comparative study of additional immune globulin and steroid pulse therapyPediatrics International, 2001
- RESPONSE OF REFRACTORY KAWASAKI DISEASE TO PULSE STEROID AND CYCLOSPORIN A THERAPYThe Pediatric Infectious Disease Journal, 2001